Milestone Pharmaceuticals Statistics Share Statistics Milestone Pharmaceuticals has 84.99M
shares outstanding. The number of shares has increased by 59.38%
in one year.
Shares Outstanding 84.99M Shares Change (YoY) 59.38% Shares Change (QoQ) 58.97% Owned by Institutions (%) 16.42% Shares Floating 83.51M Failed to Deliver (FTD) Shares 128,425 FTD / Avg. Volume 7.88%
Short Selling Information The latest short interest is 5.91M, so 6.96% of the outstanding
shares have been sold short.
Short Interest 5.91M Short % of Shares Out 6.96% Short % of Float 6.96% Short Ratio (days to cover) 4.76
Valuation Ratios The PE ratio is -3.54 and the forward
PE ratio is -2.66.
Milestone Pharmaceuticals's PEG ratio is
0.07.
PE Ratio -3.54 Forward PE -2.66 PS Ratio 0 Forward PS 19.2 PB Ratio 11.17 P/FCF Ratio -5.08 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Milestone Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 9.1,
with a Debt / Equity ratio of 4.17.
Current Ratio 9.1 Quick Ratio 9.1 Debt / Equity 4.17 Debt / EBITDA -1.3 Debt / FCF -1.9 Interest Coverage 11.76
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.26M Employee Count 33 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -259K Effective Tax Rate 0.62%
Stock Price Statistics The stock price has increased by 40.67% in the
last 52 weeks. The beta is 0.6, so Milestone Pharmaceuticals's
price volatility has been higher than the market average.
Beta 0.6 52-Week Price Change 40.67% 50-Day Moving Average 1.76 200-Day Moving Average 1.71 Relative Strength Index (RSI) 64.64 Average Volume (20 Days) 1,629,212
Income Statement
Revenue n/a Gross Profit -646K Operating Income -42.1M Net Income -41.52M EBITDA -42.1M EBIT -38.2M Earnings Per Share (EPS) -0.67
Full Income Statement Balance Sheet The company has 25.31M in cash and 54.8M in
debt, giving a net cash position of -29.48M.
Cash & Cash Equivalents 25.31M Total Debt 54.8M Net Cash -29.48M Retained Earnings -367.55M Total Assets 47.42M Working Capital 36.88M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -28.85M
and capital expenditures -33K, giving a free cash flow of -28.88M.
Operating Cash Flow -28.85M Capital Expenditures -33K Free Cash Flow -28.88M FCF Per Share -0.46
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
